Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Artra GroupTSE:6029 -2.91%59 Pretax Margin % is % as of Dec. 2025. GuruFocus rates TSE:6029 with a GF Score™ of 59/100 and a GF Value™ of 円140.45 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Artra Group ranks worse than 58.8% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Artra Group's Pre-Tax Income for the
three
months ended in Dec. 2025 was 円0 Mil. Artra Group's Revenue for the
three
months ended in Dec. 2025 was 円0 Mil. Therefore, Artra Group's pretax margin for the quarter that ended in Dec. 2025 was %.
The historical rank and industry rank for Artra Group's Pretax Margin % or its related term are showing as below:
TSE:6029'
s Pretax Margin % Range Over the Past 10 Years
Min: -16.92 Med: 1.1 Max: 17.36
Current: 1.54
TSE:6029's Pretax Margin % is ranked worse than 58.8% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 4.02
vs TSE:6029: 1.54
Artra Group (TSE:6029) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Artra Group Pretax Margin % Related Terms
Artra Group Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Artra Group's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6029 vs HCA, THC, DVA: Pretax Margin % Comparison
For the Medical Care Facilities subindustry, Artra Group's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Artra Group Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Artra Group's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Artra Group's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Artra Group (TSE:6029) has a Pretax Margin % of % as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Artra Group and its competitors. According to the industry distribution chart, Artra Group ranks #391 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 58.8%.
Is Artra Group's Pretax Margin % too high?
Artra Group's current Pretax Margin % is %. Based on the distribution chart, Artra Group ranks #391 out of 665 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Artra Group has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Artra Group's Pretax Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Artra Group ranks #391 out of 665 companies for Pretax Margin %. This places Artra Group in the lower half of its industry. The industry median Pretax Margin % is 4.02. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.02, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Artra Group and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Artra Group's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artra Group stock overvalued right now?
Based on GuruFocus' analysis, Artra Group (TSE:6029) is currently considered Significantly Overvalued. The stock's GF Value™ is 円140.45, compared to a current price of 円200.00 — trading 42.4% above its estimated fair value. The current Pretax Margin % is %. Artra Group's overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Artra Group (TSE:6029), the current Pretax Margin % is % as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Artra Group (TSE:6029) Overvalued in 2026?
Based on GuruFocus' analysis, Artra Group stock appears to be overvalued.
The current stock price of 円200.00 is trading 42.4% above its estimated GF Value™ of 円140.45.
GuruFocus considers Artra Group to be Significantly Overvalued.
Key valuation signals for TSE:6029:
Pretax Margin %: %
GF Value™: 円140.45 vs. price of 円200.00 (42.4% above fair value)
No single metric tells the full story. See the TSE:6029 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Artra Group Corp is engaged in the healthcare support business, providing services that assist the operation and management of clinics and related facilities. The group has two reportable segments: Acupuncture & Orthopedic Clinic Support and Toy Sales Business. The Acupuncture and Orthopedic Clinic Support segment is involved in supporting acupuncture and orthopedic clinics through services such as bone setting chains, provision of equipment and consumables, Attra billing services, HONEY-STYLE, and nursing care support. The Toy Sales segment focuses on the sale of toys, stationery, and other related products.
59GF Score
Get the complete analysis for TSE:6029
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6029 has been successfully added to your 
